BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27729070)

  • 1. Cytokine and human leukocyte antigen (HLA) profile for graft-versus-host disease (GVHD) after organ transplantation.
    Chen X; Meng X; Xu Y; Xie H; Yin S; Li H; Wu L; Zheng S
    Eur J Med Res; 2016 Oct; 21(1):38. PubMed ID: 27729070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines are early diagnostic biomarkers of graft-versus-host disease in liver recipients.
    Meng XQ; Chen XH; Sahebally Z; Xu YN; Yin SY; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):45-51. PubMed ID: 28119258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
    Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
    Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
    Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
    Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host disease following living donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
    Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
    Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
    Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute graft-versus-host-disease in kidney transplantation: case report and review of literature.
    Kato T; Yazawa K; Madono K; Saito J; Hosomi M; Itoh K
    Transplant Proc; 2009 Nov; 41(9):3949-52. PubMed ID: 19917421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis.
    Wakae T; Takatsuka H; Seto Y; Iwata N; Mori A; Okada M; Fujimori Y; Okamoto T; Kakishita E; Hara H
    Hematology; 2002 Oct; 7(5):305-10. PubMed ID: 12850818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
    Parra A; Ramírez-Peredo J; Reyes E; Hidalgo R; Macías-Gallardo J; Lutz-Presno J; Ruiz-Argüelles A; Garza E; Infante E; Gutiérrez-Aguirre CH; Salazar-Riojas R; Villarreal JZ; Gómez-Almaguer D; Ruiz-Argüelles GJ
    Hematology; 2012 Mar; 17(2):85-92. PubMed ID: 22664046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
    Mawad R; Hsieh A; Damon L
    Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
    Murali AR; Chandra S; Stewart Z; Blazar BR; Farooq U; Ince MN; Dunkelberg J
    Transplantation; 2016 Dec; 100(12):2661-2670. PubMed ID: 27495762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipients who receive a human leukocyte antigen-B compatible cadaveric liver allograft are at high risk of developing acute graft-versus-host disease.
    Key T; Taylor CJ; Bradley JA; Taylor AL
    Transplantation; 2004 Dec; 78(12):1809-11. PubMed ID: 15614155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation.
    Kim SJ; Park S; Rhu J; Kim JM; Choi GS; Joh JW
    Sci Rep; 2022 Nov; 12(1):20337. PubMed ID: 36434131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
    Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
    Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic graft-versus-host disease after liver transplantation: a case report.
    Yilmaz M; Ozdemir F; Akbulut S; Ersan V; Koc C; Koc S; Yilmaz S
    Transplant Proc; 2012; 44(6):1751-3. PubMed ID: 22841262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease.
    Lunn RA; Sumar N; Bansal AS; Treleaven J
    Hematology; 2005 Apr; 10(2):107-14. PubMed ID: 16019456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
    Chan EY; Larson AM; Gernsheimer TB; Kowdley KV; Carithers RL; Reyes JD; Perkins JD
    Liver Transpl; 2007 Apr; 13(4):516-22. PubMed ID: 17394149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.